Positron emission tomography (PET) for cholangiocarcinoma.
The combination of positron emission tomography (PET) with computed tomography (PET-CT) provides simultaneous metabolic and anatomic information on tumors in the same imaging session. Sensitivity of PET/PET-CT is higher for intrahepatic (>90%) than for extrahepatic cholangiocarcinoma (CCA) (about 60%). The detection rate of distant metastasis is 100%. PET, and particularly PET-CT, improves the results and impacts on the oncological management in CCA compared with other imaging modalities. Therefore, PET-CT is recommended in the preoperative staging of intrahepatic (strength of recommendation: moderate) and extrahepatic (strength of recommendation: low) CCA.
Breitenstein
S
S
Swiss HPB (Hepato-pancreato-Biliary) Center, Department of Surgery, University Hospital Zurich, Switzerland.
Apestegui
C
C
Clavien
P-A
PA
Eur J Nucl Med Mol Imaging. 2002 Aug;29(8):1047-54
12173019
J Hepatobiliary Pancreat Surg. 2003;10(6):432-40
14714164
Ann Surg. 2000 Oct;232(4):557-69
10998654
Eur J Nucl Med Mol Imaging. 2003 Nov;30(11):1467-72
14579085
J Gastroenterol Hepatol. 2008 May;23(5):759-65
17931372
J Comput Assist Tomogr. 2007 Mar-Apr;31(2):223-8
17414758
Nucl Med Commun. 2001 Dec;22(12):1277-85
11711897
Radiology. 2002 Nov;225(2):575-81
12409597
J Hepatol. 2006 Jul;45(1):43-50
16690156
Hepatology. 2001 May;33(5):1029-35
11343227